[1]
O. Basa-Dénes, R. Angi, B. Kárpáti, T. Jordán, and Z. Ötvös, “Nano-amorphous Oral Sirolimus Formulation with Improved Exposure and Low Inter-individual Variability”, Acta Pharm Hung, vol. 91, no. 3-4, pp. 181-183, Nov. 2021.